NewAmsterdam Pharma Company N.V. Stock Deutsche Boerse AG
Stocks
KH6
NL00150012L7
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.40 EUR | +6.93% |
|
+6.43% | +11.49% |
| Market Cap | 3.78B 4.32B 3.49B 3.23B 6.14B 410B 6.24B 41.82B 16.26B 203B 16.23B 15.88B 700B | P/E 2026 * |
-20.8x | P/E 2027 * | -24.5x |
|---|---|---|---|---|---|
| Enterprise Value | 3.38B 3.87B 3.12B 2.89B 5.48B 367B 5.57B 37.38B 14.54B 181B 14.51B 14.2B 626B | EV / Sales 2026 * |
145x | EV / Sales 2027 * | 24.6x |
| Free-Float |
99.09% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: NewAmsterdam Pharma Company N.V.
| 1 day | +6.93% | ||
| 1 week | +6.43% | ||
| Current month | +7.86% | ||
| 1 month | +16.88% | ||
| 3 months | +9.32% | ||
| 6 months | +8.41% | ||
| Current year | +11.49% |
| 1 week | 28.89 |  | 31.44 |
| 1 month | 24.13 | | 31.44 |
| Current year | 23.03 | | 32.68 |
| 1 year | 16.2 | | 35 |
| 3 years | 5.4 | | 35 |
| 5 years | 5.4 | | 35 |
| 10 years | 5.4 | | 35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Davidson
CEO | Chief Executive Officer | 69 | 01/11/2022 |
Mayur Somaiya
DFI | Director of Finance/CFO | 52 | 23/10/2023 |
Douglas Kling
COO | Chief Operating Officer | 53 | 01/03/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Davidson
BRD | Director/Board Member | 69 | 01/11/2022 |
John Kastelein
BRD | Director/Board Member | 72 | 01/11/2022 |
James Topper
BRD | Director/Board Member | 64 | 01/11/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.93% | +6.43% | - | - | 4.32B | |
| -1.33% | +1.01% | +72.72% | +127.99% | 57.72B | |
| -3.80% | -6.24% | +67.04% | +86.36% | 52.65B | |
| +1.67% | +7.60% | +19.76% | +464.39% | 24.46B | |
| -1.85% | -0.97% | -16.70% | -13.42% | 23.84B | |
| -3.05% | +3.06% | +42.36% | -5.66% | 19.28B | |
| -0.24% | +5.28% | +38.98% | -25.83% | 17.8B | |
| +3.46% | +17.72% | +206.66% | +364.07% | 17.29B | |
| -6.73% | +9.90% | +36.04% | - | 15.28B | |
| -1.75% | +3.74% | +28.66% | +193.55% | 14.35B | |
| Average | -0.67% | +5.15% | +55.06% | +148.93% | 26.96B | |
| Weighted average by Cap. | -1.54% | +2.58% | +57.10% | +138.41% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 23.37M 26.7M 21.54M 19.96M 37.89M 2.53B 38.51M 258M 100M 1.25B 100M 98.09M 4.32B | 132M 151M 122M 113M 214M 14.31B 217M 1.46B 567M 7.06B 566M 554M 24.41B |
| Net income | -191M -218M -176M -163M -309M -20.66B -314M -2.11B -819M -10.2B -817M -800M -35.24B | -169M -193M -155M -144M -273M -18.28B -278M -1.86B -724M -9.02B -723M -708M -31.19B |
| Net Debt | -402M -459M -370M -343M -652M -43.59B -662M -4.44B -1.73B -21.51B -1.72B -1.69B -74.35B | -538M -615M -496M -460M -873M -58.37B -887M -5.95B -2.31B -28.81B -2.31B -2.26B -99.56B |
| Date | Price | Change |
|---|---|---|
| 08/07/26 | €31.44 | +7.05% |
| 07/07/26 | €29.37 | -1.64% |
| 06/07/26 | €29.86 | -0.07% |
| 03/07/26 | €29.88 | -1.29% |
| 02/07/26 | €30.27 | +2.47% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NAMS Stock
- KH6 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
